|
|
Volumn 124, Issue 1, 2011, Pages
|
|
Letter by Papageorgiou et al regarding article, "oMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction"
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 1;
FISH OIL;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
INTERCELLULAR ADHESION MOLECULE 1;
LINOLENIC ACID;
OLIVE OIL;
OMEGA 3 FATTY ACID;
TUMOR NECROSIS FACTOR ALPHA;
CARDIAC PATIENT;
CLINICAL STUDY;
DRUG EFFECT;
DRUG EFFICACY;
FOLLOW UP;
HEART INFARCTION;
HEART MUSCLE REVASCULARIZATION;
HUMAN;
LETTER;
LIPID COMPOSITION;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SUDDEN DEATH;
SURVIVOR;
VASCULARIZATION;
DEATH, SUDDEN, CARDIAC;
DIET;
DOSE-RESPONSE RELATIONSHIP, DRUG;
ENDPOINT DETERMINATION;
EVIDENCE-BASED MEDICINE;
FATTY ACIDS, OMEGA-3;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
INTERCELLULAR ADHESION MOLECULE-1;
MYOCARDIAL INFARCTION;
MYOCARDIAL REVASCULARIZATION;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
SECONDARY PREVENTION;
TIME FACTORS;
TREATMENT OUTCOME;
TUMOR NECROSIS FACTOR-ALPHA;
|
|
EID: 79960362364
PISSN: 00097322
EISSN: 15244539
Source Type: Journal
DOI: 10.1161/CIRCULATIONAHA.110.014787 Document Type: Letter |
|
Times cited : (1)
|
|
References (4)
|
